Institutional investors purchased a net $662.6 thousand shares of CGIX during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 16.19% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
UBS FINANCIAL SERVICES, INC. Bought 205.1 Thousand shares of Cancer Genetics Inc
THE VANGUARD GROUP, INC. Bought 197.6 Thousand shares of Cancer Genetics Inc
GRANAHAN INVESTMENT MANAGEMENT, ... Bought 188.1 Thousand shares of Cancer Genetics Inc